Insta
US Pharma Major J&J Seeks Emergency Use Approval For Its Single-Shot COVID-19 Vaccine In India
(A picture of vaccine vials from Johnson and Johnson)
United States-based pharmaceutical giant Johnson and Johnson (J&J) has sought approval for its single-shot Covid-19 vaccine in India.
The development comes as another US-based firm Novavax also applied for Drug Controller General of India (DCGI)'s approval for emergency use of its Covid-19 vaccine on Thursday (5 August). Novavax has partnered with the Pune-based Serum Institute of India for manufacturing its vaccine.
In a statement issued on Friday (6 August), the J&J said it submitted its emergency use approval application on Thursday (5 August).
J&J has partnered with the Indian biotech firm Biological E for the production of its vaccine in India.
"This is an important milestone that paves the way to bringing our single-dose COVID-19 vaccine to the people of India, and the rest of the world, through a collaboration with Biological E. Limited," the company said in a statement.
"Biological E will be an important part of our global supply chain network, helping to supply our Johnson & Johnson Covid-19 vaccine through the extensive collaborations and partnerships we have with governments, health authorities and organisations such as Gavi and the COVAX facility," it added.
J&J's vaccine developed by Janssen Pharmaceutical Companies of Johnson & Johnson comprises one shot and reportedly found to have 85.4 per cent efficacy against severe disease and 93.1 per cent against hospitalisation, reports Hindustan Times.
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.
Latest
